Navigation Links
Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
Date:9/15/2008

VEENENDAAL, Netherlands, September 15 /PRNewswire/ --

- Oncentra(R) RT Viewer* Officially to Launch at ESTRO 2008 in Gothenburg, Sweden, September 14-18 and ASTRO 2008, Boston, USA, September 21-24

Nucletron, a knowledge-based leader in radiation oncology today announced the market release of Oncentra RT Viewer. This unique innovation in treatment planning solutions from Nucletron allows clinicians to review radiotherapy plans that are generated with a wide variety of DICOM-compliant treatment planning systems, in a Windows PC-based environment.

Oncentra RT Viewer makes it possible to review and share treatment planning data, such as DICOM RT Images, RT Structure sets, RT Plans and RT doses, on any computer, making it a powerful tool for clinical consulting and peer-to-peer reviewing. Oncentra RT Viewer therefore is a great alternative for reviewing and sharing treatment planning data with paper hardcopies. This solution allows the digital sharing of plans on the hospital's network, or on any other electronic sharing device.

"Oncentra RT Viewer makes data distribution very easy and efficient. It allows reviewing treatment plans and sharing knowledge with colleagues, anywhere and anytime, ultimately resulting in improving patient care," says Paul van den Biggelaar, Director of New Product Development at Nucletron.

Oncentra RT Viewer will be available for demonstration at ESTRO, Nucletron Booth B02:50 from September 14-18, as well as ASTRO, Nucletron Booth 1602 from September 21-24.

* Oncentra RT Viewer is not currently available for sale in North America, pending regulatory clearance.

About Nucletron

Nucletron is a knowledge-based leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams - reconfiguring traditional boundaries between customer and solution provider. Many Nucletron employees have clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians. For more information, visit http://www.nucletron.com.


'/>"/>
SOURCE Nucletron B V
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nucletron Announces Oncentra(R) Brachy* Treatment Planning Solution for Multimodality Environment
2. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
3. CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
4. Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
5. Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit
6. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
7. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
8. Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment
9. Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices
10. Chromos announces shareholder approval of Arrangement
11. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... maternal age to IVF success. , After comparing the results from the fresh ...
(Date:10/10/2017)... CALIF. (PRWEB) , ... October 10, 2017 , ... San ... part of its corporate rebranding initiative announced today. The bold new look is ... reach, as the company moves into a significant growth period. , It will also ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
Breaking Biology News(10 mins):